SEC Form 4 · accession 0001140361-18-013317
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2018 | F | 974 | $51.84 | D | 35,756 | D | |
| Common StockF2,F3 | Mar 12, 2018 | S | 5,842 | $52.82 | D | 29,914 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.50 to $53.16, inclusive.